Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate-risk prostate cancer at high risk of distant recurrence and cancer-specific mortality-Reference-Cited by-同舟云学术

Detectable end of radiation prostate specific antigen assists in identifying men with unfavorable intermediate-risk prostate cancer at high risk of distant recurrence and cancer-specific mortality

Published:2018-03-09 Issue:8 Volume:78 Page:623-630
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Hayman Jonathan¹^ORCID,Phillips Ryan²,Chen Di³,Perin Jamie⁴,Narang Amol K.²,Trieu Janson²,Radwan Noura²,Greco Stephen²,Deville Curtiland²,McNutt Todd²,Song Daniel Y.²⁵,DeWeese Theodore L.²⁵,Tran Phuoc T.²⁵

Affiliation:

1. Department of Internal Medicine; Johns Hopkins Bayview Hospital; Baltimore Maryland

2. Department of Radiation Oncology and Molecular Radiation Sciences; Johns Hopkins Hospital; Baltimore Maryland

3. Department of Pediatrics; Johns Hopkins School of Medicine; Baltimore Maryland

4. Department of International Health; Johns Hopkins Bloomberg School of Public Health; Baltimore Maryland

5. Departments of Oncology and Urology; Johns Hopkins Hospital; Baltimore Maryland

Funder

Movember Foundation

Nesbitt Family

Publisher

Wiley

Subject

Urology,Oncology

Reference16 articles.

1. Prostate cancer, version 1.2016;Mohler;J Natl Compr Canc Netw,2016

2. A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy;Zumsteg;Eur Urol,2013

3. End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation for prostate cancer;Tran;J Clin Oncol,2015

4. End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer;Narang;Prostate Cancer Prostatic Dis,2017

5. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference;Roach;Int J Radiat Oncol Biol Phys,2006